Royal Bank of Canada
NVLN

Royal Bank of Canada’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Royal Bank of Canada’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-447
Closed – – 7394
2019
Q3 		$0 Hold
447
– – ﹤0.01% 7415
2019
Q2 		$0 Sell
447
-212
-32% -$236 ﹤0.01% 7411
2019
Q1 		$1K Buy
659
+169
+34% +$192 ﹤0.01% 6738
2018
Q4 		$0 Buy
490
+51
+12% +$58 ﹤0.01% 7420
2018
Q3 		$1K Sell
439
-203
-32% -$719 ﹤0.01% 6650
2018
Q2 		$2K Buy
642
+115
+22% +$462 ﹤0.01% 6312
2018
Q1 		$1K Buy
527
+265
+101% +$1.12K ﹤0.01% 6259
2017
Q4 		$0 Sell
262
-1,234
-82% -$5.93K ﹤0.01% 7151
2017
Q3 		$11K Buy
1,496
+1,240
+484% +$9.94K ﹤0.01% 6248
2017
Q2 		$2K Sell
256
-67
-21% -$645 ﹤0.01% 6331
2017
Q1 		$3K Buy
323
+87
+37% +$889 ﹤0.01% 6388
2016
Q4 		$2K Buy
+236
New +$2.09K ﹤0.01% 6507

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Royal Bank of Canada's NVLN Position: Q4 2019 in Review

Royal Bank of Canada sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 447 shares.

Royal Bank of Canada first reported a position in NVLN in Q4 2016 and held it in 12 quarters. The position peaked at $11K in Q3 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Royal Bank of Canada reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 447 Novelion Therapeutics Inc. Common Shares shares in Q4 2019.
  • Royal Bank of Canada first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 12 quarters.
  • Royal Bank of Canada's Novelion Therapeutics Inc. Common Shares position peaked at $11K in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.